Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis

NCT02364986 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Relapsing-remitting Multiple Sclerosis

Interventions

DRUG: Rebif®
DRUG: Avonex

Sponsor

PD Dr. Marcus Müller

Collaborators

[object Object]
[object Object]